142 related articles for article (PubMed ID: 24954590)
1. Dynorphins in regulation of immune system functions.
Gein SV
Biochemistry (Mosc); 2014 May; 79(5):397-405. PubMed ID: 24954590
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
Tan-No K; Cebers G; Yakovleva T; Hoon Goh B; Gileva I; Reznikov K; Aguilar-Santelises M; Hauser KF; Terenius L; Bakalkin G
Exp Cell Res; 2001 Sep; 269(1):54-63. PubMed ID: 11525639
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the conformational requirements for binding to the kappa-opioid receptor and its subtypes. I. Novel alpha-helical cyclic peptides and their role in receptor selectivity.
Collins N; Hruby VJ
Biopolymers; 1994 Sep; 34(9):1231-41. PubMed ID: 7948735
[TBL] [Abstract][Full Text] [Related]
4. Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?
Qiu F; Liang CL; Liu H; Zeng YQ; Hou S; Huang S; Lai X; Dai Z
Oncotarget; 2017 Jan; 8(1):268-284. PubMed ID: 27902485
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors.
Aldrich JV; Zheng QI; Murray TF
Chirality; 2001; 13(3):125-9. PubMed ID: 11270320
[TBL] [Abstract][Full Text] [Related]
6. Content of dynorphins and kappa-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice.
Jamensky NT; Gianoulakis C
Alcohol Clin Exp Res; 1997 Nov; 21(8):1455-64. PubMed ID: 9394118
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship studies of dynorphin A and related peptides.
Naqvi T; Haq W; Mathur KB
Peptides; 1998; 19(7):1277-92. PubMed ID: 9786179
[TBL] [Abstract][Full Text] [Related]
8. Dynorphin regulates the phagocytic activity of splenic phagocytes in wall lizards: involvement of a κ-opioid receptor-coupled adenylate-cyclase-cAMP-PKA pathway.
Kumar S; Rai U
J Exp Biol; 2011 Dec; 214(Pt 24):4217-22. PubMed ID: 22116765
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
10. A novel N-terminal cyclic dynorphin A analogue cyclo(N,5)[Trp(3),Trp(4),Glu(5)] dynorphin A-(1-11)NH(2) that lacks the basic N-terminus.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2003 Apr; 46(8):1279-82. PubMed ID: 12672226
[TBL] [Abstract][Full Text] [Related]
11. Kappa-opioid receptor-mediated modulation of innate immune response by dynorphin in teleost Channa punctatus.
Singh R; Rai U
Peptides; 2010 May; 31(5):973-8. PubMed ID: 20132853
[TBL] [Abstract][Full Text] [Related]
12. NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor.
O'Connor C; White KL; Doncescu N; Didenko T; Roth BL; Czaplicki G; Stevens RC; Wüthrich K; Milon A
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11852-7. PubMed ID: 26372966
[TBL] [Abstract][Full Text] [Related]
13. Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.
Kumar V; Guo D; Marella M; Cassel JA; Dehaven RN; Daubert JD; Mansson E
Bioorg Med Chem Lett; 2008 Jun; 18(12):3667-71. PubMed ID: 18487043
[TBL] [Abstract][Full Text] [Related]
14. The role of the dynorphin/κ opioid receptor system in anxiety.
Hang A; Wang YJ; He L; Liu JG
Acta Pharmacol Sin; 2015 Jul; 36(7):783-90. PubMed ID: 25982631
[TBL] [Abstract][Full Text] [Related]
15. Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the kappa-opioid receptor does not affect dynorphin A(1-13) affinity and function.
Ferguson DM; Kramer S; Metzger TG; Law PY; Portoghese PS
J Med Chem; 2000 Apr; 43(7):1251-2. PubMed ID: 10753461
[No Abstract] [Full Text] [Related]
16. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
Bell KM; Traynor JR
Can J Physiol Pharmacol; 1998 Mar; 76(3):325-33. PubMed ID: 9673796
[TBL] [Abstract][Full Text] [Related]
17. Radioligand-dependent discrepancy in agonist affinities enhanced by mutations in the kappa-opioid receptor.
Hjorth SA; Thirstrup K; Schwartz TW
Mol Pharmacol; 1996 Oct; 50(4):977-84. PubMed ID: 8863844
[TBL] [Abstract][Full Text] [Related]
18. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
Vig BS; Zheng MQ; Murray TF; Aldrich JV
J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity.
Granucci F; Zanoni I; Feau S; Ricciardi-Castagnoli P
EMBO J; 2003 Jun; 22(11):2546-51. PubMed ID: 12773371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
